Elsevier

Talanta

Volume 225, 1 April 2021, 121898
Talanta

Review
Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages

https://doi.org/10.1016/j.talanta.2020.121898Get rights and content

Highlights

  • In vitro diagnosis (IVD) platforms play a very relevant role to stop pandemic.

  • Companies compete on be the first on validating and regulating their technology.

  • Analysis of commercialized Covid-19 diagnosis technologies under different regulation.

  • Real time RT-PCR analysis and rapid immune tests are the main technologies emerged.

  • Critical comparison of IVD technologies in the market to counterattack this pandemic.

Abstract

The current situation of the Covid-19 pandemic is indicated by a huge number of infections, high lethality, and rapid spread. These circumstances have stopped the activity of almost the entire world, affecting severely the global economy. A rapid diagnosis of the Covid-19 and a generalized testing protocol is essential to fight against the pandemic and to maintain health control in the population.

Principal biosensing and diagnostic technologies used to monitor the spread of the SARS-CoV-2 are based on specific genomic analysis and rapid immune tests, both with different technology platforms that include advantages and disadvantages. Most of the in vitro diagnosis companies are competing to be the first on validating under different regulations their technology for placing their platforms for Covid-19 detection as fast as possible in this big international market.

A comprehensive analysis of the commercialized technologies for the genomic based sensing and the antibody/antigen detection methods devoted to Covid-19 diagnosis is described in this review, which have been detailed and listed under different countries regulations. The effectiveness of the described technologies throughout the different stages of the disease and a critical comparison of the emerging technologies in the market to counterattack this pandemic have been discussed.

Keywords

Covid-19
SARS-CoV-2
In vitro diagnosis (IVD)
Reverse transcriptase polymerase chain reaction (RT-PCR)
Point of care (POC)
Lateral flow immunoassay

Cited by (0)

View Abstract